Invitrogen Corporation to Present at the UBS Warburg 2007 Global Life Science Conference

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today that Greg Lucier, Chairman and Chief Executive Officer, will present at the UBS 2007 Global Life Science Conference being held at the Grand Hyatt, Park Avenue at Grand Central Terminal in New York City. The company will present on Tuesday, September 25th, 2007 at 9:30 a.m. (ET). The company presentation will be webcast live and is accessible via Invitrogen’s website at www.invitrogen.com. A replay of the webcast will be available after the conference on the Investor Relations section of the website.

MORE ON THIS TOPIC